Health Care & Life Sciences » Pharmaceuticals | Ascendis Pharma A/S

Ascendis Pharma A/S

Ascendis Pharma A/S ADR
Stock Exchange NASDAQ Stock Market
EPS
$3.87
Market Cap
$5.27 B
Shares Outstanding
46.3 M
Public Float
38.01 M

Profile

Address
Tuborg Boulevard 12
Hellerup CR 2900
Denmark
Employees -
Website http://www.ascendispharma.com
Updated 07/08/2019
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.

Financials

View All

Michael Wolff Jensen
Chairman, SVP & General Counsel
Jan Møller Mikkelsen
President, Chief Executive Officer & Director